PMC:7105881 / 32780-33208 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1037","span":{"begin":25,"end":29},"obj":"Gene"},{"id":"1045","span":{"begin":63,"end":68},"obj":"Species"},{"id":"1046","span":{"begin":133,"end":141},"obj":"Species"},{"id":"1047","span":{"begin":231,"end":239},"obj":"Species"},{"id":"1050","span":{"begin":82,"end":95},"obj":"Disease"},{"id":"1051","span":{"begin":107,"end":115},"obj":"Disease"},{"id":"1052","span":{"begin":197,"end":205},"obj":"Disease"},{"id":"1053","span":{"begin":212,"end":220},"obj":"Disease"},{"id":"1055","span":{"begin":176,"end":182},"obj":"CellLine"},{"id":"1057","span":{"begin":374,"end":382},"obj":"Species"},{"id":"1085","span":{"begin":413,"end":421},"obj":"Species"}],"attributes":[{"id":"A1037","pred":"tao:has_database_id","subj":"1037","obj":"Gene:59272"},{"id":"A1045","pred":"tao:has_database_id","subj":"1045","obj":"Tax:9606"},{"id":"A1046","pred":"tao:has_database_id","subj":"1046","obj":"Tax:694009"},{"id":"A1047","pred":"tao:has_database_id","subj":"1047","obj":"Tax:694009"},{"id":"A1050","pred":"tao:has_database_id","subj":"1050","obj":"MESH:D054198"},{"id":"A1051","pred":"tao:has_database_id","subj":"1051","obj":"MESH:D007239"},{"id":"A1052","pred":"tao:has_database_id","subj":"1052","obj":"MESH:D008223"},{"id":"A1053","pred":"tao:has_database_id","subj":"1053","obj":"MESH:D007239"},{"id":"A1055","pred":"tao:has_database_id","subj":"1055","obj":"CVCL:0511"},{"id":"A1057","pred":"tao:has_database_id","subj":"1057","obj":"Tax:694009"},{"id":"A1085","pred":"tao:has_database_id","subj":"1085","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T181","span":{"begin":69,"end":78},"obj":"Body_part"},{"id":"T182","span":{"begin":82,"end":95},"obj":"Body_part"},{"id":"T183","span":{"begin":96,"end":100},"obj":"Body_part"},{"id":"T184","span":{"begin":161,"end":168},"obj":"Body_part"},{"id":"T185","span":{"begin":183,"end":188},"obj":"Body_part"},{"id":"T186","span":{"begin":192,"end":196},"obj":"Body_part"},{"id":"T187","span":{"begin":339,"end":346},"obj":"Body_part"}],"attributes":[{"id":"A181","pred":"fma_id","subj":"T181","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A182","pred":"fma_id","subj":"T182","obj":"http://purl.org/sig/ont/fma/fma83030"},{"id":"A183","pred":"fma_id","subj":"T183","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A184","pred":"fma_id","subj":"T184","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A185","pred":"fma_id","subj":"T185","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A186","pred":"fma_id","subj":"T186","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A187","pred":"fma_id","subj":"T187","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T169","span":{"begin":42,"end":45},"obj":"Disease"},{"id":"T170","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T171","span":{"begin":190,"end":205},"obj":"Disease"},{"id":"T173","span":{"begin":197,"end":205},"obj":"Disease"},{"id":"T174","span":{"begin":231,"end":239},"obj":"Disease"},{"id":"T175","span":{"begin":352,"end":356},"obj":"Disease"},{"id":"T176","span":{"begin":374,"end":382},"obj":"Disease"},{"id":"T177","span":{"begin":413,"end":421},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0019383"},{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0004095"},{"id":"A172","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0015759"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"},{"id":"A174","pred":"mondo_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A176","pred":"mondo_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A177","pred":"mondo_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T431","span":{"begin":3,"end":5},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T432","span":{"begin":63,"end":68},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T433","span":{"begin":69,"end":78},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T434","span":{"begin":96,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0000031"},{"id":"T435","span":{"begin":176,"end":180},"obj":"http://purl.obolibrary.org/obo/CLO_0008734"},{"id":"T436","span":{"begin":176,"end":180},"obj":"http://purl.obolibrary.org/obo/CLO_0051728"},{"id":"T437","span":{"begin":181,"end":188},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T438","span":{"begin":190,"end":196},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T439","span":{"begin":350,"end":351},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T194","span":{"begin":161,"end":168},"obj":"Chemical"},{"id":"T195","span":{"begin":339,"end":346},"obj":"Chemical"}],"attributes":[{"id":"A194","pred":"chebi_id","subj":"T194","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A195","pred":"chebi_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":190,"end":205},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012191"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"2_test","denotations":[{"id":"32265848-17049691-36511134","span":{"begin":253,"end":257},"obj":"17049691"},{"id":"32265848-22311359-36511135","span":{"begin":273,"end":277},"obj":"22311359"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-sentences","denotations":[{"id":"T197","span":{"begin":374,"end":412},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T543","span":{"begin":25,"end":29},"obj":"G_3;PG_10;PR:000003622"},{"id":"T544","span":{"begin":63,"end":68},"obj":"SP_6;NCBITaxon:9606"},{"id":"T545","span":{"begin":69,"end":78},"obj":"CL:0000576"},{"id":"T546","span":{"begin":133,"end":141},"obj":"SP_10"},{"id":"T547","span":{"begin":142,"end":152},"obj":"GO:0010467"},{"id":"T548","span":{"begin":153,"end":158},"obj":"NCBITaxon:10239"},{"id":"T549","span":{"begin":159,"end":168},"obj":"PG_1"},{"id":"T550","span":{"begin":181,"end":188},"obj":"CL:0000236"},{"id":"T551","span":{"begin":190,"end":196},"obj":"CL:0000236"},{"id":"T552","span":{"begin":231,"end":239},"obj":"SP_10"},{"id":"T553","span":{"begin":337,"end":346},"obj":"PG_1"},{"id":"T554","span":{"begin":352,"end":356},"obj":"SP_10"},{"id":"T555","span":{"begin":374,"end":382},"obj":"SP_10"},{"id":"T556","span":{"begin":413,"end":421},"obj":"SP_10"},{"id":"T24672","span":{"begin":25,"end":29},"obj":"G_3;PG_10;PR:000003622"},{"id":"T34596","span":{"begin":63,"end":68},"obj":"SP_6;NCBITaxon:9606"},{"id":"T78001","span":{"begin":69,"end":78},"obj":"CL:0000576"},{"id":"T51847","span":{"begin":133,"end":141},"obj":"SP_10"},{"id":"T5780","span":{"begin":142,"end":152},"obj":"GO:0010467"},{"id":"T88105","span":{"begin":153,"end":158},"obj":"NCBITaxon:10239"},{"id":"T44559","span":{"begin":159,"end":168},"obj":"PG_1"},{"id":"T7143","span":{"begin":181,"end":188},"obj":"CL:0000236"},{"id":"T24600","span":{"begin":190,"end":196},"obj":"CL:0000236"},{"id":"T5374","span":{"begin":231,"end":239},"obj":"SP_10"},{"id":"T12423","span":{"begin":337,"end":346},"obj":"PG_1"},{"id":"T58430","span":{"begin":352,"end":356},"obj":"SP_10"},{"id":"T2784","span":{"begin":374,"end":382},"obj":"SP_10"},{"id":"T54867","span":{"begin":413,"end":421},"obj":"SP_10"}],"text":"I (FcγRII)-dependent and ACE2-independent ADE, particularly in human monocytic or lymphoblastic cell lines infected with pseudotyped SARS-CoV expressing viral S protein, or in Raji B cells (B-cell lymphoma line) infected with live SARS-CoV (Kam et al., 2007; Jaume et al., 2012), raising significant concerns over the use of full-length S protein as a SARS vaccine target.\n\nSARS-CoV Subunit Vaccines Based on RBD\nSARS-CoV RBD co"}